Waldencast Acquisition Corp. Class A WALD 深 滬
等待開盤 09-11 09:30:00 美东时间
1.68
-0.170
-9.19%
華盛通- 最 高1.91
- 今 開1.90
- 成交量 31.85万股
- 最 低 1.66
- 昨 收 1.85
- 總市值 2.07亿
- 52周最高 4.18
- 市盈率 靜 --
- 換手率 0.26%
- 52周最低 1.4801
- 委 比 -50.86%
- 總股本 1.23亿
- 歷史最高 12.10
- 量 比 1.79
- 振 幅 13.51%
- 歷史最低 1.4801
- 每 手 1
- 風險率 0.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Waldencast Says FDA Approves Obagi Saypha MagIQ Injectable Hyaluronic Acid Gel
Waldencast plc (NASDAQ:WALD), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration ("FDA") has approved Obagi® saypha® MagIQ™ injectable
09-10 18:50
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
Waldencast's Obagi Medical brand has received FDA approval for Obagi® saypha® MagIQ™, its first HA dermal filler, marking entry into the U.S. market and doubling Obagi's addressable market to $4.2B by 2029. Planned U.S. launch in 2026, the product leverages Obagi's skincare network for enhanced value. Developed by Croma-Pharma, it uses proprietary MACRO Core Technology for natural results. The product met clinical trial endpoints for safety and e...
09-10 10:45
Waldencast Reports Strategic Growth and New Acquisitions
Waldencast Acquisition Corp. ( ($WALD) ) has released its Q2 earnings. Here is ...
08-26 12:00
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
Waldencast plc reported strong H1 2025 performance, with Obagi Medical achieving double-digit growth in core channels and Milk Makeup delivering high-teens retail sales growth in the U.S. Obagi's acquisition of Novaestiq Corp doubles its addressable market in the U.S., while Milk Makeup expanded its digital presence through Amazon Premium Beauty. The company launched a strategic review to enhance shareholder value and postponed its H1 earnings re...
08-18 21:43
Earnings Scheduled For August 18, 2025
Companies Reporting Before The Bell • SUNation Energy (NASDAQ:SUNE) is likely t...
08-18 16:32
美股大行评级 | 潜在涨幅95.33%！HC Wainwright & Co.上调Insmed目标价至240美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Insmed"买入"评级，目标价从120美元升至240美元；巴克莱：维持Transocean"超配"评级，目标价从3.5美元升至4美元
08-14 09:25
Telsey Advisory Group Maintains Outperform on Waldencast, Maintains $4 Price Target
Telsey Advisory Group analyst Dana Telsey maintains Waldencast (NASDAQ:WALD) with a Outperform and maintains $4 price target.
08-14 05:37
Waldencast Strengthens Obagi Medical With Saypha Injectable Line And Novaestiq Acquisition, Expanding Into $2B US Dermal Filler Market
Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolioNew products position Obagi Medical at the forefront of health, beauty and aesthetics convergence
07-23 18:51
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Waldencast plc has acquired Novaestiq Corp. and the U.S. rights to Saypha® hyaluronic acid (HA) injectable gels, expanding Obagi Medical's product offerings into the growing U.S. dermal filler market. The acquisition aims to position Obagi Medical as a leader in integrated skincare and aesthetic solutions. Saypha®, which is undergoing FDA approval, is a globally recognized, effective, and safe HA injectable with a strong clinical backing and pati...
07-23 10:45
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining aroun...
06-26 20:16
